FDA Revokes Emergency Use Authorization for Janssen COVID-19 Vaccine

Summary

The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, issued to Janssen Biotech, Inc., due to the revocation under the Federal Food, Drug, and Cosmetic Act (FD&C Act), effective June 1, 2023.